| 000 | 03141cam a2200757 i 4500 | ||
|---|---|---|---|
| 001 | 21999573 | ||
| 003 | 35767 | ||
| 005 | 20251121171246.0 | ||
| 008 | 210419t20222022caua b 001 0 eng d | ||
| 010 | _a 2021937456 | ||
| 015 |
_aGBC159217 _2bnb |
||
| 016 | 7 |
_a020162370 _2Uk |
|
| 020 |
_a9780357375952 _q(paperback) |
||
| 020 |
_a0357375955 _q(paperback) |
||
| 035 | _a21999573 | ||
| 035 | _a(OCoLC)1247943649 | ||
| 040 |
_aUKMGB _beng _cUKMGB _erda _dOCLCO _dOCLCF _dYDX _dEAU _dAAA _dOCLCO _dDLC |
||
| 041 | _aeng | ||
| 042 | _alccopycat | ||
| 050 | 0 | 0 |
_aRM316 _b.M231 2022 |
| 082 | 0 | 4 |
_a616.86 M231 2022 _223 |
| 100 | 1 |
_aMaisto, Stephen A., _eauthor. |
|
| 245 | 1 | 0 |
_aDrug use and misuse / _cStephen A. Maisto, Mark Galizio, Gerard J. Connors. |
| 246 | 3 | _aDrug use and abuse | |
| 250 | _aNinth edition. | ||
| 264 | 1 |
_aBoston, MA : _bCengage, _cc2022. |
|
| 300 |
_axvii, 543 pages : _billustrations (some color) ; _c26 cm |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 500 | _aPrevious edition: 2019. | ||
| 504 | _aIncludes bibliographical references (pages 490-520) and index. | ||
| 505 | 0 | _aDrug use and misuse -- Drug use Uesterday and Today -- Drugs and the Nervous system -- Pharmacology -- Psychopharmacology and New Drug Development -- Cocaine, Amphetamines, and related stimulants -- Nicotine -- Caffeine -- Alcohol -- Opiates -- Marijuana -- Hallucinogens -- sychotherapeutic medications -- Other Prescription and over-the-counter drugs -- Treatment of substance use disorders -- Prevention of substance misuse. | |
| 526 | _a600 Technology (Applied Sciences) | ||
| 650 | 0 | _aSubstance abuse. | |
| 650 | 0 | _aDrugs of abuse. | |
| 650 | 0 |
_aDrugs _xPhysiological effect. |
|
| 650 | 0 | _aPsychopharmacology. | |
| 650 | 0 | _aDrug addiction. | |
| 650 | 0 |
_aDrug addiction _xPrevention. |
|
| 650 | 0 |
_aDrug addiction _xTreatment. |
|
| 650 | 0 | _aDrug abuse. | |
| 650 | 0 |
_aDrug abuse _xTreatment. |
|
| 650 | 2 | _aPsychopharmacology | |
| 650 | 2 | _aSubstance-Related Disorders | |
| 650 | 6 | _aPolytoxicomanie. | |
| 650 | 6 |
_aMédicaments _xEffets physiologiques. |
|
| 650 | 6 | _aPsychopharmacologie. | |
| 650 | 6 | _aToxicomanie. | |
| 650 | 6 |
_aToxicomanie _xTraitement. |
|
| 650 | 7 |
_asubstance abuse. _2aat |
|
| 650 | 7 |
_adrug abuse. _2aat |
|
| 650 | 7 |
_adrug addiction. _2aat |
|
| 650 | 7 |
_aDrug addiction. _2fast _0(OCoLC)fst01430217 |
|
| 650 | 7 |
_aDrug addiction _xPrevention. _2fast _0(OCoLC)fst01430226 |
|
| 650 | 7 |
_aDrug addiction _xTreatment. _2fast _0(OCoLC)fst01430233 |
|
| 650 | 7 |
_aDrugs of abuse. _2fast _0(OCoLC)fst00898981 |
|
| 650 | 7 |
_aDrugs _xPhysiological effect. _2fast _0(OCoLC)fst00898862 |
|
| 650 | 7 |
_aPsychopharmacology. _2fast _0(OCoLC)fst01081659 |
|
| 650 | 7 |
_aSubstance abuse. _2fast _0(OCoLC)fst01136767 |
|
| 700 | 1 |
_aGalizio, Mark, _eauthor. |
|
| 700 | 1 |
_aConnors, Gerard J. _q(Gerard Joseph), _d1952- _eauthor. |
|
| 906 |
_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cB |
||
| 999 |
_c40335 _d40335 |
||